Millennium Management
NPCE icon

Millennium Management’s Neuropace NPCE Stock Holding History

Millennium Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$534K Sell
40,621
-53,114
-57% -$797K ﹤0.01% 4734
2025
Q4 		$1.45M Buy
+93,735
New +$1.25M ﹤0.01% 4213
2025
Q2 		– Sell
-268,716
Closed -$3.3M – 6190
2025
Q1 		$3.3M Sell
268,716
-374,495
-58% -$4.69M ﹤0.01% 3288
2024
Q4 		$7.2M Sell
643,211
-96,782
-13% -$842K ﹤0.01% 2478
2024
Q3 		$5.16M Buy
739,993
+53,956
+8% +$395K ﹤0.01% 2813
2024
Q2 		$5.19M Buy
686,037
+80,324
+13% +$810K ﹤0.01% 2690
2024
Q1 		$8M Buy
605,713
+433,310
+251% +$6.18M ﹤0.01% 2406
2023
Q4 		$1.78M Sell
172,403
-11,766
-6% -$93.8K ﹤0.01% 3706
2023
Q3 		$1.79M Sell
184,169
-444,764
-71% -$2.6M ﹤0.01% 3661
2023
Q2 		$2.82M Sell
628,933
-102,677
-14% -$465K ﹤0.01% 3184
2023
Q1 		$3.4M Buy
731,610
+39,711
+6% +$152K ﹤0.01% 2951
2022
Q4 		$1.03M Buy
691,899
+106,532
+18% +$237K ﹤0.01% 4133
2022
Q3 		$2.19M Buy
585,367
+78,462
+15% +$378K ﹤0.01% 3655
2022
Q2 		$2.51M Buy
506,905
+83,877
+20% +$554K ﹤0.01% 3473
2022
Q1 		$3.47M Buy
423,028
+304,391
+257% +$2.63M ﹤0.01% 3343
2021
Q4 		$1.2M Sell
118,637
-86,809
-42% -$1.13M ﹤0.01% 4244
2021
Q3 		$3.26M Sell
205,446
-48,792
-19% -$1.02M ﹤0.01% 3360
2021
Q2 		$6.05M Buy
+254,238
New +$5.9M ﹤0.01% 2504

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management's NPCE Position: Q1 2026 in Review

Millennium Management reduced its Neuropace (NPCE) stake by 57% in Q1 2026, selling an estimated $797K and leaving 40,621 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #4734.

Millennium Management first reported a position in NPCE in Q2 2021 and has held it in 18 quarters since. The position peaked at $8M in Q1 2024. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Millennium Management held 40,621 shares of Neuropace worth $534K as of Q1 2026.
  • Millennium Management sold 53,114 Neuropace shares in Q1 2026, an estimated $797K.
  • Neuropace made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4734 holding.
  • Millennium Management first reported a position in Neuropace in Q2 2021 and has held it in 18 quarters since.
  • Millennium Management's Neuropace position peaked at $8M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.